10.16.26 -- Cancer Innovation, Trial Strategy, And AI Manufacturing

To truly maximize enrollment in decentralized models, sponsors must invest in human connection to build the trust needed to move patients from awareness to active participation.

Managing PV across dozens of markets strains even experienced safety teams. Learn about a framework that helps you maintain compliance, reduce risk, and scale confidently into new markets.

A new study finds fewer than half of EU Clinical Trial Information System (CTIS) trials met results reporting requirements. The EMA is now watching more closely. Here’s what sponsors need to know.

Visit-based or procedure-based? The right payment model can improve budget accuracy, site satisfaction, data timeliness, and overall trial performance

AI can only improve production when it can see, understand, and safely act on shop floor data. Learn how governed orchestration turns disconnected systems into scalable manufacturing performance.

Discover why this life sciences hub stands out with top talent, robust R&D capabilities, and strong government investment driving innovation and growth.